Correlation Between Immix Biopharma and Freeline Therapeutics

Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Freeline Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Freeline Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immix Biopharma and Freeline Therapeutics Holdings, you can compare the effects of market volatilities on Immix Biopharma and Freeline Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Freeline Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Freeline Therapeutics.

Diversification Opportunities for Immix Biopharma and Freeline Therapeutics

0.0

Correlation Coefficient

Immix Biopharma  Freeline Therapeutics

Pay attention - limited upside

The 3 months correlation between Immix and Freeline is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Freeline Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freeline Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Freeline Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freeline Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Freeline Therapeutics go up and down completely randomly.

Pair Corralation between Immix Biopharma and Freeline Therapeutics

If you would invest (100.00) in Freeline Therapeutics Holdings on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Freeline Therapeutics Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Immix Biopharma  vs.  Freeline Therapeutics Holdings

Immix Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Freeline Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Immix Biopharma and Freeline Therapeutics

The main advantage of trading using opposite Immix Biopharma and Freeline Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Freeline Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freeline Therapeutics will offset losses from the drop in Freeline Therapeutics' long position.

The idea behind Immix Biopharma and Freeline Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.